Protagonist Therapeutics, Inc.PTGXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-311.04%
↑ 92% vs avg
Percentile
P38
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-3911.28%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -311.04% | -632.7% |
| 2024 | 58.39% | +138.8% |
| 2023 | -150.57% | +68.7% |
| 2022 | -481.56% | -7.0% |
| 2021 | -449.87% | -102.6% |
| 2020 | -222.05% | +99.3% |
| 2019 | -33335.93% | -26201.5% |
| 2018 | -126.75% | +30.4% |
| 2017 | -182.18% | - |